Author: Jesse Landry

There’s something beautifully ironic about naming your cybersecurity startup North Pole Security, because in a world flooded with post-breach excuses and cold comfort solutions, these guys are the ones actually keeping things locked up tight. No jingle bells, just binary approvals and real-time enforcement for the only enterprise OS still pretending it doesn’t need serious protection: macOS. Today, North Pole Security announced a $4 million seed round led by Andreessen Horowitz, with backing from Royal Hansen and a collection of angel investors who clearly know what it means when Google’s security veterans stop talking and start building. This isn’t another…

Wallarm just closed a $55M Series C, led by Toba Capital, and this wasn’t a polite handshake. It was a global power move from a team that didn’t just spot the storm coming in API and AI security, they built a platform that is the storm. Founded by Ivan Novikov and Alexander Golovko, Wallarm didn’t emerge from the Y Combinator S16 batch with dreams, they came with code. Real, functional, AI-first, high-scale architecture engineered to defend APIs against threats most companies haven’t even named yet. Ivan’s not your average cybersecurity CEO. He’s the kind of guy who used to poke…

Here’s Motive, an AI-powered juggernaut turning chaos into command across trucking, logistics, construction, and the industries that quite literally keep the lights on. Let’s just say, while Silicon Valley was busy A/B testing photo filters, Motive was building the backbone for 120,000+ businesses to run smarter, safer, and with fewer surprises. This isn’t just a “fleet management” play, this is the operating system for everything that moves on wheels, rigs, or reality. Born in 2013 as KeepTruckin, the founding crew, Shoaib Makani, Ryan Johns, and Obaid Khan, weren’t looking to reinvent the logbook. They digitized it, scaled it, then torched…

When it comes to feeding innovation, most baby bottle brands are still dancing to elevator music while the next generation of parents is streaming Kendrick, Cardi, and Coltrane on shuffle. Then there’s Emulait, a science-led brand out of San Francisco that decided to remix the baby care industry using 3D scanning, patented nipple technology, and a whole lot of clinical muscle. Founded in 2021 by serial med-tech builder Shilo Ben Zeev, Emulait isn’t chasing the infant feeding market, it’s reconstructing it from the inside out. The company’s mission? Simple on paper, brutal in practice: close the gap between breast and…

There’s something about a company called Observe pulling in $156 million in Series C to teach enterprises how to actually see what the hell is going on inside their systems. Because here’s the reality: in 2025, observability isn’t a dashboard, it’s survival. And most companies are still out here playing Where’s Waldo with their telemetry data, hoping an alert magically connects dots it never even knew existed. Observe, Inc. just dropped the mic on that mess. With a fresh $156M led by Sutter Hill Ventures and support from Madrona Ventures, Alumni Ventures, Capital One Ventures, and Snowflake Ventures, they’re not…

The difference between a prototype and a product? Infrastructure. And in the AI coding world, that line isn’t just blurry, it’s brutal. Runloop just dropped a $7M seed round to erase it. Not with buzzwords, but with battle-tested dev boxes built for the kind of autonomous agents that don’t just autocomplete, they build, break, and rebuild software like it’s second nature. Founded in late 2023 by Jonathan Wall, Runloop isn’t your average “former Big Tech” story. Jonathan co-founded Google Wallet and brought tap-to-pay to the U.S. before co-founding Index, sold to Stripe in 2018. So, when he says there’s a…

In a world drowning in AI vaporware and glorified demo reels, Matrice.ai didn’t show up to pitch PowerPoints. They showed up to build factories. Not steel-and-smoke factories, but Vision AI Factories, modular and real, designed for enterprise environments that don’t have time for sci-fi. Their system doesn’t dream about the future; it’s too busy deploying it, across oil fields, stadiums, smart cities, and retail operations that move faster than most startups can spell inference. Founded in 2022, Amar Krishna, Dr. Dipendra Jha, and Dr. Reda Al-Bahrani didn’t stack resumes, they built a team with 30+ years of ML street cred.…

San Francisco may be the HQ, but this story starts in Sweden, with two young minds, a few gold medals, and a conviction that AI shouldn’t just think, it should do. Tzafon just locked in $9.7M in pre-seed funding, now officially holding the crown for Sweden’s largest pre-seed round in history. Not bad for a company that didn’t exist 12 months ago. What are they building? Not another LLM wrapper with a PowerPoint deck and a dream. Tzafon is developing scalable multiagent AI systems, real infrastructure that thinks in actions, not outputs. At the core? Two Swedish co-founders: Noah Löfquist,…

If you think fashion’s future is about color palettes and seasonal drops, you’re stuck on the wrong runway. Real innovation doesn’t come wrapped in recycled marketing, it’s buried in the seams, stitched deep into the molecules. And that’s exactly where Ambercycle is working its alchemy. Born out of a UC Davis dorm room and fueled by frustration with the 92 million tons of annual textile waste, Shay Sethi (CEO) and Moby Ahmed (CTO) didn’t just brainstorm another green fashion brand. They engineered a molecular regeneration process so slick, it turns trashed threads into Cycora, a virgin-quality regenerated polyester that performs…

You can’t fix the global antibiotic pipeline with hope and prayer, or whatever it is pharma’s been using to stall the collapse. Enter Kinvard Bio, out of Raleigh, North Carolina. And before you ask: yes, it’s a Harvard spin-out. But this one’s got actual horsepower under the hood, not just a crimson bumper sticker. Kinvard Bio just secured a $2.7 million non-dilutive follow-on grant from CARB-X, that’s Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator for the uninitiated. It’s not easy money. It’s milestone-triggered, rigor-tested capital for companies tackling the Everest of drug discovery: antimicrobial resistance. With this round, Kinvard Bio’s confirmed funding…